News
Mersana Therapeutics Inc. (NASDAQ:MRSN) is one of the best penny stocks under $1 to buy now. Earlier in June, Mersana ...
Context Therapeutics Inc. (NASDAQ:CNTX) is one of the best penny stocks under $1 to buy now. Earlier in June, Context ...
A different study presented at the 2025 ASCO Annual Meeting showed that one specific diet may benefit people with colon ...
45mon MSN
Guardant Health Enrolls First Patient in NCI Vanguard Study for Multi-Cancer Detection Test
The Vanguard Study was initiated following review and approval by the US FDA as part of the NCI’s submission for an ...
An expert discusses how optimal sequencing of therapies remains unclear in lower-risk MDS, with emerging combination ...
Pfizer Inc. (NYSE: PFE) announced today the completion of a global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK) ...
The Casablanca-based Oncorad Group has become the first cancer treatment center in Africa to publish research in “Advances in Radiation Oncology,” in partnership with the American Society for ...
Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical company pioneering advanced treatments for cancers ...
US FDA extends the review period for GSK’s Blenrep combinations to treat relapsed/refractory multiple myeloma: London, UK Friday, July 25, 2025, 11:00 Hrs [IST] GSK plc announce ...
No one wants to hear the words: "You have cancer." But about 1 in 8 American women will learn they have breast cancer, according to the Centers for Disease Control and Prevention. "Breast ...
A virus from humble black-eyed peas is showing extraordinary promise in the fight against cancer. Unlike other plant viruses, ...
Rebecca Chacko, MD, discussed exciting advancements in breast cancer care and the future role of emerging therapeutic strategies for early recurrence detection, as part of her panelist role at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results